Novel Approaches to the Management of Recurrent Pregnancy Loss: The OPTIMUM (OPtimization of Thyroid Function, Thrombophilia, Immunity, and Uterine Milieu) Treatment Strategy
Overview
Authors
Affiliations
Purpose: Does the OPtimization of Thyroid function, Thrombophilia, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy, developed for treating repeated implantation failure (RIF), contribute to improving pregnancy outcomes in patients with a history of recurrent pregnancy loss (RPL)?
Methods: Between 2018 and 2019, women with RPL after two or more clinical pregnancy losses underwent RPL testing. We treated chronic endometritis with antibiotics, high Th1/Th2 cell ratios with vitamin D and/or tacrolimus, overt/subclinical hypothyroidism with levothyroxine, and thrombophilia with low-dose aspirin. Of 168 consecutive women aged ≤43 years, 115 underwent RPL testing. We compared 100 pregnancies (90 women) and 46 pregnancies (41 women) with and without the OPTIMUM treatment strategy, respectively.
Results: RPL testing identified intrauterine abnormalities in 66 (57.4%), elevated Th1/Th2 cell ratios in 50 (43.5%), thyroid dysfunction in 33 (28.7%), and thrombophilia in 33 (28.7%). The live birth rate in the OPTIMUM group was significantly higher than that in the control group among women aged <40 years (78.1% and 42.3%, respectively; = 0.002), but no significant difference was observed in women aged ≥40 years (55.6% and 30.0%, respectively; = 0.09).
Conclusions: The OPTIMUM treatment strategy improved pregnancy outcomes in patients with not only RIF but also RPL.
Bulletti F, Sciorio R, Conforti A, De Luca R, Bulletti C, Palagiano A Front Endocrinol (Lausanne). 2025; 15:1429193.
PMID: 40028443 PMC: 11867936. DOI: 10.3389/fendo.2024.1429193.
Garmendia J, De Sanctis C, Hajduch M, De Sanctis J Int J Mol Sci. 2025; 26(3).
PMID: 39941063 PMC: 11818386. DOI: 10.3390/ijms26031295.
Management strategies following implantation failure of euploid embryos.
Kuroda K Reprod Med Biol. 2024; 23(1):e12576.
PMID: 38590944 PMC: 11000815. DOI: 10.1002/rmb2.12576.
Kuroda K Reprod Med Biol. 2024; 23(1):e12561.
PMID: 38249354 PMC: 10797160. DOI: 10.1002/rmb2.12561.
Kuroda K, Horikawa T, Moriyama A, Ojiro Y, Takamizawa S, Watanabe H Reprod Med Biol. 2023; 22(1):e12554.
PMID: 38144238 PMC: 10739138. DOI: 10.1002/rmb2.12554.